An Australian study examining the effects of cannabis on insomnia has been approved by the Therapeutics Goods Administration for the first time.
The trial will be conducted by the University of Western Australia’s Centre for Sleep Science and pharmaceutical company Zelda Therapeutics.
Overseas data has shown anecdotal evidence of the benefits of cannabis when used to treat insomnia.
The randomised controlled trial is expected to commence in the first quarter of 2018.
